DKS Co. Ltd.
第一工業製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4461
FY2025 · 2026-03-31
| Gross margin | 29.9% |
| Operating margin | 12.2% |
| Net margin | 7.4% |
| Return on equity | 13.5% |
| Return on assets | 5.4% |
| Revenue growth (YoY) | 13.1% |
| EPS (basic) | ¥606.28 |
| EPS growth (YoY) | 124.5% |
| Current ratio | 1.75x |
| Equity ratio | 39.7% |
| Book value / share | ¥4,904.22 |
| Free cash flow | 6,340 M |